Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 581.03M | $ 271.69M | 46.76% |
3/31/2025 | $ 490.93M | $ 133.53M | 27.2% |
12/31/2024 | $ 465.99M | $ 141.72M | 30.41% |
9/30/2024 | $ 519.11M | $ 145.81M | 28.09% |
6/30/2024 | $ 569.38M | $ 158.72M | 27.88% |
3/31/2024 | $ 629.22M | $ 170.57M | 27.11% |
12/31/2023 | $ 573.97M | $ 183.34M | 31.94% |
9/30/2023 | $ 633.79M | $ 196.54M | 31.01% |
6/30/2023 | $ 682.46M | $ 207.92M | 30.47% |
3/31/2023 | $ 747.83M | $ 220.41M | 29.47% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for REGENXBIO INC is calculated as follows: Debt [ $ 61.02M ] / Assets [ $ 541.17M ]
(=) Debt to Assets [ 11.28% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |